Search

Displaying results 2611 - 2620 of 10000 in total
  1. Drug

    Bulevirtide

    go.drugbank.com/drugs/DB15248
    ApprovedInvestigational

    It was first approved for use in the EU on May 28, 2020; bulevirtide has been granted PRIME scheme eligibility and Orphan Drug Designation by the European Medicines Agency. … Hepatitis D is considered the most severe type of viral hepatitis and leads to the rapid development of cirrhosis, severe decompensation of liver function, and an increased risk of mortality.

    Categories: Amino Acids, Peptides, and Proteins
  2. Drug

    Omega-3-carboxylic acids

    go.drugbank.com/drugs/DB09568
    ApprovedWithdrawn

    The omega-3 carboxylic acid (OM3-CA) is a new formulation of omega-3 fatty acids that present an enhanced bioavailability in the treatment of dyslipidemia. … [A25808] It was developed by AstraZeneca Pharmaceuticals and firstly approved by the FDA on May 05, 2014.[L2386]

    Mixtures: BiO-LiFE MaxX Fish Oil 1000mg Soft Capsule
  3. Indication

    Meningitis

    go.drugbank.com/conditions/DBCOND0014275
    Drugs: Benzylpenicillin · Cefoperazone · Cefuroxime · Metronidazole
    Synonyms: Meningitis due to other and unspecified causes
  4. Indication

    Proctosigmoiditis

    go.drugbank.com/conditions/DBCOND0020742
    Drugs: Mesalazine
    Synonyms: Noninfective gastroenteritis and colitis, unspecified
  5. Drug

    Gliclazide

    go.drugbank.com/drugs/DB01120
    ApprovedInvestigational

    Gliclazide is extensively metabolized by the liver; its metabolites are excreted in both urine (60-70%) and feces (10-20%). … Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).

    Categories: Drugs Used in Diabetes, Alimentary Tract and MetabolismProducts: Gliavis IR Tablet 80mg, Rolazide Tablet 80mg
  6. Drug

    Dacomitinib

    go.drugbank.com/drugs/DB11963
    ApprovedInvestigational

    Dacomitinib, designed as (2E)-N-16-4-(piperidin-1-yl) but-2-enamide, is an oral highly selective quinazalone part of the second-generation tyrosine kinase inhibitors which are characterized by the irreversible … [A40009] Dacomitinib was developed by Pfizer Inc and approved by the FDA on September 27, 2018.

    Categories: Antineoplastic and Immunomodulating AgentsProducts: VIZIMPRO FILM-COATED TABLET 30MG, VIZIMPRO FILM-COATED TABLET 15MG
  7. Drug

    Fenoldopam

    go.drugbank.com/drugs/DB00800
    Approved

    A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

    Categories: Adrenergic and Dopaminergic Agents
  8. Indication

    Tinea Cruris

    go.drugbank.com/conditions/DBCOND0041588
    Drugs: Amorolfine · Butenafine · Ciclopirox · Clioquinol · Clotrimazole · Econazole +9 more
    Synonyms: Dermatophytosis of groin and pubic area, Dermatophytosis of groin and pubic area (disorder)
  9. Indication

    Vesicular Palmoplantar Eczema

    go.drugbank.com/conditions/DBCOND0036754
    Drugs: Methylprednisolone aceponate · Urea
    Synonyms: Vesicular eczema of hands and feet, Vesicular eczema of hands and/or feet (disorder)
  10. Indication

    Aspiration Pneumonitis

    go.drugbank.com/conditions/DBCOND0075845
    Drugs: Cortisone acetate · Dexamethasone · Hydrocortisone · Methylprednisolone · Prednisolone · Prednisone
    Synonyms: Pneumonitis due to inhalation of food and vomit